Publication | Closed Access

Olanzapine versus amisulpride and placebo in the treatment of negative symptoms and deficit states of chronic schizophrenia

PsychiatryPsychotic DisorderMedicinePsychotropic MedicationOlanzapine Versus AmisulpridePsychopharmacologyDepressionSchizophreniaNeuropharmacologyChronic SchizophreniaPharmacotherapySocial SciencesBiological PsychiatryNegative SymptomsPharmacologyPsychopathology